Correlation Between Checkpoint Therapeutics and Fortress Biotech

Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Fortress Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Fortress Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Checkpoint Therapeutics and Fortress Biotech Pref, you can compare the effects of market volatilities on Checkpoint Therapeutics and Fortress Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Fortress Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Fortress Biotech.

Diversification Opportunities for Checkpoint Therapeutics and Fortress Biotech

-0.2

Correlation Coefficient

Checkpoint Therapeutics  Fortress Biotech

Good diversification

The 3 months correlation between Checkpoint and Fortress is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Fortress Biotech Pref in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fortress Biotech Pref and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Fortress Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fortress Biotech Pref has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Fortress Biotech go up and down completely randomly.

Pair Corralation between Checkpoint Therapeutics and Fortress Biotech

Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 1.18 times more return on investment than Fortress Biotech. However, Checkpoint Therapeutics is 1.18 times more volatile than Fortress Biotech Pref. It trades about 0.29 of its potential returns per unit of risk. Fortress Biotech Pref is currently generating about -0.03 per unit of risk. If you would invest  221.00  in Checkpoint Therapeutics on September 1, 2024 and sell it today you would earn a total of  218.00  from holding Checkpoint Therapeutics or generate 98.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Checkpoint Therapeutics  vs.  Fortress Biotech Pref

Checkpoint Therapeutics

Risk-Adjusted Performance

23 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Checkpoint Therapeutics are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Checkpoint Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Fortress Biotech Pref

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fortress Biotech Pref has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Preferred Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Checkpoint Therapeutics and Fortress Biotech

The main advantage of trading using opposite Checkpoint Therapeutics and Fortress Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Fortress Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will offset losses from the drop in Fortress Biotech's long position.

The idea behind Checkpoint Therapeutics and Fortress Biotech Pref pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.